[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fdDQ35wCFKg-EIidgtR55mNVKFn4a0YkzgvgAD-SFtwc":8,"$fefGxOqqcXU02Gd_0XGPSVHJFhD0V2p9_jKdSgGPDR9U":55,"$fi_F5ed_HzSxBoZ1r-reR3AE23NJn6W2ldYuLRl2g2II":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},58924,867323,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//VjxO4NeO7R7u8VxE20BMmMakCRoDYTJ8.png","徐家亮","瓦房店市中心医院","肿瘤科","主任医师",99,0,"肺癌晚期小细胞癌常用药品使用要点解析🌿","","https://ystcdn.venuertc.com/venue/AI/ae46c860-ca2e-4a91-b6c0-3d267dd8be68.jpg","\u003Cdiv class=\"lungcancer_drugguide-container\">\n  \u003Ch1 id=\"material_title\" class=\"lungcancer_drugguide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌晚期小细胞癌常用药品使用要点解析🌿\u003C/h1>\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg1\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">一、导入：化疗、放疗、免疫药物的正确用法，你是否都了解？🔑\u003C/h2>\n    \u003Cp class=\"lungcancer_drugguide-text\">\n      在实际治疗中，依托泊苷、卡铂、伊立替康与PD-1抑制剂等药物是晚期小细胞肺癌患者最常面临的选择。这些药物的使⽤细节、相互作用、不良反应、存储方式与剂量调整对疗效影响明显。本篇内容，从药理到实操，总结7个必须知道的要点，助你明明白白、安全有效用药。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg2\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">二、药品成分与剂型全览\u003C/h2>\n    \u003Cul class=\"lungcancer_drugguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">依托泊苷：\u003C/span>\n        注射剂与口服胶囊，白色粉末溶解为无色液体。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">卡铂：\u003C/span>\n        注射用无色澄明溶液。需严格在医疗人员操作下稀释后静脉滴注。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">伊立替康：\u003C/span>\n        黄绿色澄明液体，只用于静脉输注。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">PD-1抑制剂（如纳武利尤单抗等）：\u003C/span>\n        单克隆抗体注射液，无色至微黄色澄明溶液，仅支持静脉给药。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungcancer_drugguide-fact\">\n      \u003Cspan class=\"lungcancer_drugguide-facticon\">🧪\u003C/span>\n      各剂型均需专业人员配制，患者不得自行操作。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg3\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">三、药物作用机制的核心要点🔬\u003C/h2>\n    \u003Cul class=\"lungcancer_drugguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">依托泊苷：\u003C/span>\n        抑制拓扑异构酶Ⅱ，阻断肿瘤细胞DNA复制。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">卡铂：\u003C/span>\n        通过形成DNA交联，影响肿瘤细胞增殖。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">伊立替康：\u003C/span>\n        抑制拓扑异构酶Ⅰ，干扰DNA合成与修复。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">PD-1抑制剂：\u003C/span>\n        解除肿瘤细胞对免疫系统的抑制，激活T细胞识别肿瘤。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungcancer_drugguide-hint\">\n      \u003Cspan class=\"lungcancer_drugguide-facticon\">💡\u003C/span>\n      作用原理不同，联合用药有协同效应，但同时增加副作用风险。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg4\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">四、使用方法与给药时间\u003C/h2>\n    \u003Col class=\"lungcancer_drugguide-orderedlist\">\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">静脉注射：\u003C/span>\n        依托泊苷、卡铂及伊立替康均应由医护人员静脉输注；注射速度和溶剂浓度需严格控制，可显著降低局部刺激及系统毒性。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">口服制剂：\u003C/span>\n        若用依托泊苷胶囊，建议餐前或餐后1小时用足量温水送服，切勿掰开或咀嚼，防止药效丧失或胃肠道刺激加重。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">免疫药物：\u003C/span>\n        如PD-1抑制剂，一般每2-3周静脉注射一次，时长30-60分钟。注射期间建议静坐并监测反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">化疗周期：\u003C/span>\n        常见方案为每21-28天一周期，疗程和方案以个体反应为依据，由医生调整。漏服或间断需告知医护，严禁自行补药。\n      \u003C/li>\n    \u003C/ol>\n    \u003Cdiv class=\"lungcancer_drugguide-tip\">\n      正确做法：每次用药前核对药品标签，按医嘱用药，并注意服用时间的准确性。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg5\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">五、用药期间的关键注意事项⚠️\u003C/h2>\n    \u003Cul class=\"lungcancer_drugguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">依托泊苷：\u003C/span>\n        不得与环孢素A等CYP3A4抑制剂同用，否则药物浓度易上升，毒性风险增大（参考：van der Bol et al., 2011）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">卡铂：\u003C/span>\n        肾功能不全时浓度升高，应密切监测肾功能，必要时调整剂量。如联合氨基糖苷类抗生素，肾毒性、耳毒性增强。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">伊立替康：\u003C/span>\n        合并酮康唑或圣约翰草类制剂影响代谢，慎用。出现腹泻应立刻报告医疗人员。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">PD-1抑制剂：\u003C/span>\n        联合激素类和免疫抑制剂会降低疗效。疫苗接种需提前告知医生，避免活疫苗。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungcancer_drugguide-hint\">\n      \u003Cspan class=\"lungcancer_drugguide-facticon\">🔎\u003C/span>\n      药物组合复杂时，宜随身携带详尽用药清单，并告知所有就诊医生。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg6\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">六、特殊人群用药与禁忌事项\u003C/h2>\n    \u003Cul class=\"lungcancer_drugguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">老年人：\u003C/span>\n        依托泊苷及卡铂在65岁以上人群中，骨髓抑制风险明显上升。初始剂量宜适度下调，密切监测血象（参考：Quoix et al., 2011）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">儿童：\u003C/span>\n        仅在医疗团队评估后选用，剂量需严格参考体表面积，监测副反应。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">孕妇/哺乳期：\u003C/span>\n        化疗药、伊立替康和PD-1抑制剂严格禁用，影响胎儿/婴儿免疫与发育（FDA分级D/X类）。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">肾/肝功能不全：\u003C/span>\n        卡铂和伊立替康对肾肝损伤高度敏感，应精准调整剂量或暂停使用。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungcancer_drugguide-tip\">\n      特别提醒：属于以上人群请主动咨询专业医生，切勿自行加减停药。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg7\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">七、常见不良反应识别与处理办法\u003C/h2>\n    \u003Cul class=\"lungcancer_drugguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">依托泊苷：\u003C/span>\n        易致白细胞和血小板减少，发生率约25-40%。一旦出现持续高热或出血，需立即就医。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">卡铂：\u003C/span>\n        恶心、呕吐和肾功能损害发生率高于顺铂，同步应用止吐药能有效减轻症状。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">伊立替康：\u003C/span>\n        腹泻分为急性与延迟性。急性型可用阿托品缓解，延迟型需大剂量补液并及时补充电解质。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">PD-1抑制剂：\u003C/span>\n        皮疹、甲状腺功能异常、肺炎和轻中度腹泻为主要副反应，如发现持续乏力、黄疸、呼吸急促等情况需暂停用药并速报医生（参考：Antonia et al., 2016）。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungcancer_drugguide-tip\">\n      正确做法：用药期间带好随访本或不良反应自查表，异常及时报医护。\n    \u003C/div>\n    \u003Cdiv class=\"lungcancer_drugguide-case\">\n      \u003Cspan class=\"lungcancer_drugguide-facticon\">📋\u003C/span>\n      案例：有患者在连续数周期依托泊苷+卡铂方案期间，出现骨髓抑制及感染发热，加用升白细胞药后配合抗感染治疗恢复。提示监测血象的重要性。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg8\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">八、药物存储和使用安全细节\u003C/h2>\n    \u003Cul class=\"lungcancer_drugguide-list\">\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">依托泊苷：\u003C/span>\n        储存于2-8°C冷藏环境，防止阳光直射。开瓶后剩余药物4小时内用完。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">卡铂：\u003C/span>\n        避光保存于25°C以下。配制后尽快使用，勿与金属容器混存。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">伊立替康：\u003C/span>\n        需冷藏，配制好的输液24小时内用毕。高温（＞30°C）使药效明显降低。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"lungcancer_drugguide-label\">PD-1抑制剂：\u003C/span>\n        需2-8°C冷藏，切勿冷冻。原瓶密封储存，开封后短时间内使用完毕。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungcancer_drugguide-tip\">\n      正确做法：若药液混浊、变色或瓶身膨胀，请勿使用并报药师。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg9\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">九、漏服与过量处理\u003C/h2>\n    \u003Cul class=\"lungcancer_drugguide-list\">\n      \u003Cli>化疗和免疫药主要为医护操作，极少家庭自用。若出现配伍错误或剂量偏差，务必第一时间报告医疗人员。\u003C/li>\n      \u003Cli>如患者自行漏服口服依托泊苷，切忌擅自补服，可记录时间并及时联系医生。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"lungcancer_drugguide-tip\">\n      特别警示：任何未按医嘱用药行为都有风险，发现过量用药第一时间寻求医疗协助。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg10\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">十、结语：科学用药，治疗更安心☀️\u003C/h2>\n    \u003Cp class=\"lungcancer_drugguide-text\">\n      无论是依托泊苷、卡铂、伊立替康还是PD-1抑制剂，每个细节都影响疗效与安全。重点记住：严格按医嘱、按周期用药，警惕不良反应，及时与医护沟通。安全、规范地使用这些抗肿瘤药物，是帮助患者获得更多治疗机会的关键一步。合理掌握药品知识，就能让治疗之路走得更稳更远⛳。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Cdiv class=\"lungcancer_drugguide-section lungcancer_drugguide-bg11\">\n    \u003Ch2 class=\"lungcancer_drugguide-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"lungcancer_drugguide-refs\">\n      \u003Cli>\n        Antonia, S. J., Villegas, A., Daniel, D., et al. (2016). Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 377(20), 1919-1929. doi:10.1056/NEJMoa1709937\n      \u003C/li>\n      \u003Cli>\n        van der Bol, J. M., Mathijssen, R. H., Loos, W. J., et al. (2011). A CYP3A4 phenotyping probe and prediction of etoposide and docetaxel pharmacokinetics. \u003Ci>Clinical Pharmacology & Therapeutics\u003C/i>, 90(4), 631-636. doi:10.1038/clpt.2011.164\n      \u003C/li>\n      \u003Cli>\n        Quoix, E., Zalcman, G., Oster, J. P., et al. (2011). Carboplatin and etoposide in elderly patients with small-cell lung cancer: conclusions of a phase II study. \u003Ci>Annals of Oncology\u003C/i>, 22(1), 161-166. doi:10.1093/annonc/mdq321\n      \u003C/li>\n    \u003C/ol>\n    \u003Cp class=\"lungcancer_drugguide-text\">\n      *相关数据及药品使用细节亦参照各国家药品说明书及权威用药指南\n    \u003C/p>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.lungcancer_drugguide-container {\n  font-family: 'Segoe UI', Arial, sans-serif;\n  max-width: 820px;\n  margin: 40px auto 50px auto;\n  background: #fcfcfc;\n  border-radius: 16px;\n  box-shadow: 0 6px 22px rgba(50,60,65,0.11);\n  padding: 32px 32px 32px 32px;\n}\n.lungcancer_drugguide-title {\n  font-size: 2.3rem;\n  font-weight: 700;\n  color: #266163;\n  margin-bottom: 38px;\n  text-align: center;\n  letter-spacing: 0.04em;\n}\n\n.lungcancer_drugguide-section {\n  margin-bottom: 38px;\n  padding: 22px 24px 24px 24px;\n  border-radius: 13px;\n  position: relative;\n}\n\n.lungcancer_drugguide-subtitle {\n  font-size: 1.32rem;\n  font-weight: 600;\n  color: #26435c;\n  margin-bottom: 13px;\n  line-height: 1.45em;\n  letter-spacing: 0.015em;\n}\n\n.lungcancer_drugguide-bg1 {\n  background: linear-gradient(to right, #f7fcfa 70%, #e0f7fa 120%);\n  border-left: 7px solid #b3e5fc;\n}\n.lungcancer_drugguide-bg2 {\n  background: linear-gradient(135deg,#f1fbe7 60%, #eaf9ec 120%);\n  border-left: 7px solid #c5e1a5;\n}\n.lungcancer_drugguide-bg3 {\n  background: linear-gradient(120deg,#f9f4ec 60%, #f7efe7 130%);\n  border-left: 7px solid #ffe082;\n}\n.lungcancer_drugguide-bg4 {\n  background: linear-gradient(125deg,#f5f8fa 60%, #e5ecf0 130%);\n  border-left: 7px solid #91d2ee;\n}\n.lungcancer_drugguide-bg5 {\n  background: linear-gradient(110deg,#f2f4f7 70%, #fae6e6 140%);\n  border-left: 7px solid #f99e9e;\n}\n.lungcancer_drugguide-bg6 {\n  background: linear-gradient(90deg,#fff7e6 70%, #ffeede 140%);\n  border-left: 7px solid #fbc982;\n}\n.lungcancer_drugguide-bg7 {\n  background: linear-gradient(105deg,#f6f4f7 80%, #e4e7ee 130%);\n  border-left: 7px solid #bab2e9;\n}\n.lungcancer_drugguide-bg8 {\n  background: linear-gradient(120deg,#f4f5fb 60%, #e3eefb 120%);\n  border-left: 7px solid #aac6ff;\n}\n.lungcancer_drugguide-bg9 {\n  background: linear-gradient(115deg,#fbfef2 70%, #eaf8c7 120%);\n  border-left: 7px solid #c7ea46;\n}\n.lungcancer_drugguide-bg10 {\n  background: linear-gradient(120deg,#fafdff 80%, #d4e9ff 120%);\n  border-left: 7px solid #8bbedb;\n}\n.lungcancer_drugguide-bg11 {\n  background: #f8fafb;\n  border-left: 7px solid #b0c6d9;\n}\n\n.lungcancer_drugguide-list, .lungcancer_drugguide-orderedlist {\n  margin-top: 5px;\n  margin-bottom: 16px;\n  padding-left: 22px;\n  color: #354458;\n}\n.lungcancer_drugguide-list li {\n  margin-bottom: 7px;\n  font-size: 1.08em;\n}\n.lungcancer_drugguide-orderedlist {\n  list-style-type: decimal;\n  margin-left: 7px;\n  color: #2d4059;\n}\n.lungcancer_drugguide-orderedlist li {\n  margin-bottom: 8px;\n  font-size: 1.06em;\n}\n\n.lungcancer_drugguide-label {\n  font-weight: 600;\n  color: #176583;\n  margin-right: 4px;\n}\n\n.lungcancer_drugguide-hint, .lungcancer_drugguide-tip, .lungcancer_drugguide-fact, .lungcancer_drugguide-case {\n  background: #f2f8fa;\n  border-left: 5px solid #58b1c1;\n  border-radius: 8px;\n  padding: 9px 17px;\n  margin-bottom: 13px;\n  margin-top: 10px;\n  font-size: 1.03em;\n  display: flex;\n  align-items: center;\n}\n.lungcancer_drugguide-tip {\n  background: #f8fbe7;\n  border-left: 5px solid #bfd656;\n}\n.lungcancer_drugguide-fact {\n  background: #e8f6fc;\n  border-left: 5px solid #75c3e2;\n}\n.lungcancer_drugguide-case {\n  background: #f3eefa;\n  border-left: 5px solid #ba80da;\n}\n.lungcancer_drugguide-facticon {\n  font-size: 1.45em;\n  margin-right: 9px;\n}\n\n.lungcancer_drugguide-text {\n  font-size: 1.13em;\n  color: #3a484f;\n  margin-top: 3px;\n  margin-bottom: 6px;\n  line-height: 1.72em;\n}\n\n.lungcancer_drugguide-refs {\n  padding-left: 18px;\n  margin-top: 9px;\n  margin-bottom: 6px;\n}\n.lungcancer_drugguide-refs li {\n  font-size: 1em;\n  color: #424d57;\n  margin-bottom: 7px;\n}\n@media screen and (max-width: 650px) {\n  .lungcancer_drugguide-container {\n    padding: 12px 7px 26px 7px;\n    max-width: 99%;\n    font-size: 0.98em;\n  }\n  .lungcancer_drugguide-title {\n    font-size: 1.39rem;\n    padding-top: 12px;\n  }\n  .lungcancer_drugguide-section {\n    padding: 13px 6px 13px 10px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"lungcancer_drugguide-container\">\n  \u003Ch1 id=\"material_title\" class=\"lungcancer_drugguide-t",553,"2025-08-14 10:56:39","小细胞肺癌, 化疗药物, 免疫药物, 用药注意事项, 不良反应","了解晚期小细胞肺癌的化疗、放疗和免疫药物的正确使用方法，掌握用药时的注意事项和不良反应处理，确保治疗安全有效。","2025-08-16 14:48:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]